Loading...
OTCMSONVY
Market cap19bUSD
Dec 20, Last price  
66.20USD
1D
1.95%
1Q
-3.75%
Jan 2017
174.57%
IPO
175.83%
Name

Sonova Holding AG

Chart & Performance

D1W1MN
OTCM:SONVY chart
P/E
5.90
P/S
0.98
EPS
10.08
Div Yield, %
6.95%
Shrs. gr., 5y
-1.76%
Rev. gr., 5y
5.59%
Revenues
3.63b
-2.98%
660,375,000866,682,0001,072,796,0001,204,779,0001,249,197,0001,500,306,0001,616,700,0001,619,848,0001,795,262,0001,951,312,0002,035,085,0002,071,929,9992,395,650,0002,645,900,0002,763,200,0002,916,900,0002,601,900,0003,363,900,0003,738,400,0003,626,900,000
Net income
601m
-7.18%
95,024,000172,474,000241,629,000274,140,000284,110,000354,813,000231,010,000246,761,000110,917,000340,830,000359,994,000337,026,000349,172,000400,135,000454,100,000483,200,000581,000,000649,000,000647,500,000601,000,000
CFO
753m
-1.32%
101,871,000165,539,000279,223,000303,759,000281,767,000427,725,000344,642,000304,806,000387,053,000411,028,000459,457,000428,443,000522,390,999523,400,000533,200,000840,400,000754,700,000922,500,000763,400,000753,300,000
Dividend
Jun 14, 20241.07038 USD/sh
Earnings
May 12, 2025

Profile

Sonova Holding AG designs, develops, manufactures, and distributes hearing care solutions for adults and children. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The company offers wireless communication products; rechargeable hearing aids; wireless headsets, speech enhanced hearables, audiophile headphones, microphones, and wireless transmission systems; and audiological care services. It also provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand; consumer hearing products under the Sennheiser brand; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton brands. The company sells its products through independent distributors; and provides hearing care services through a network of approximately 3,600 stores and clinics. It operates in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
IPO date
Apr 23, 2009
Employees
17,608
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
3,626,900
-2.98%
3,738,400
11.13%
3,363,900
29.29%
Cost of revenue
2,956,400
3,008,600
2,609,700
Unusual Expense (Income)
NOPBT
670,500
729,800
754,200
NOPBT Margin
18.49%
19.52%
22.42%
Operating Taxes
37,800
57,300
64,600
Tax Rate
5.64%
7.85%
8.57%
NOPAT
632,700
672,500
689,600
Net income
601,000
-7.18%
647,500
-0.23%
649,000
11.70%
Dividends
(274,100)
(267,600)
(201,600)
Dividend yield
1.76%
1.65%
0.83%
Proceeds from repurchase of equity
(31,400)
(486,500)
(731,700)
BB yield
0.20%
3.00%
3.01%
Debt
Debt current
79,300
78,600
403,900
Long-term debt
1,994,400
1,736,200
1,080,400
Deferred revenue
158,000
186,400
189,900
Other long-term liabilities
159,900
404,000
456,100
Net debt
1,473,500
1,328,700
808,000
Cash flow
Cash from operating activities
753,300
763,400
922,500
CAPEX
(128,600)
(154,300)
(106,600)
Cash from investing activities
(234,000)
(429,500)
(707,000)
Cash from financing activities
(415,300)
(523,500)
(1,372,700)
FCF
423,900
573,200
672,300
Balance
Cash
513,800
414,800
612,000
Long term investments
86,400
71,300
64,300
Excess cash
418,855
299,180
508,105
Stockholders' equity
2,495,100
2,660,300
3,153,800
Invested Capital
4,184,945
3,941,920
3,661,895
ROIC
15.57%
17.69%
20.25%
ROCE
14.17%
16.76%
17.50%
EV
Common stock shares outstanding
59,791
60,433
62,711
Price
261.10
-2.79%
268.60
-30.70%
387.60
54.79%
Market cap
15,611,380
-3.83%
16,232,338
-33.22%
24,306,786
53.54%
EV
17,105,780
17,579,938
25,137,086
EBITDA
916,700
969,500
965,300
EV/EBITDA
18.66
18.13
26.04
Interest
28,200
23,100
34,500
Interest/NOPBT
4.21%
3.17%
4.57%